prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Final Surgical Pathology Report. Procedure. Diagnosis. A. Sentinel lymph node, right axilla, biopsy: Two negative lymph. nodes (0/2). B. Breast, right, excisional biopsy: Invasive ductal carcinoma, grade 2, size not less than 2.5 cm,. present at the medial and posterior margins; see microscopic. description. Ductal carcinoma in-situ, grade 2, present at the inferior. margin. Microscopic Description: Invasive Carcinoma: Histologic type: Ductal. Histologic grade: 2. Overall grade: 7/9. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT2) : Not less than 2.5 cm, and possibly as. much as 4.0 cm (invasive carcinoma extends away from the main. tumor mass into the surrounding fat throughout much of the. specimen). Specimen margins: Invasive carcinoma is broadly present at. the medial and posterior margins. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Histologic pattern: Solid, cribriform. Nuclear grade: 2. Central Necrosis: Focal. % DCIS of total tumor (if mixed) : 28. Extensive intraductal component (present/absent) : Absent. Specimen margins: DCIS is at the inferior margin of the. specimen. Calcification: Negative. Comments: Two prior biopsy sites are identified in the mid-portion of. the specimen. There is a confluence of tumor present microscopically. between the two apparent masses formed by the tumor, supporting the. conclusion of a single tumor mass lesion. Additionally, there is. tumor infiltrating around and beyond the tumor mass areas, into the. surrounding fat, and to the specimen margins as stated above. p63. immunostaining performed to confirm the presence of invasive carcinoma. at the margin. E-cadherin performed to exclude LCIS and confirm DCIS. at the inferior margin. Cytokeratin immunostaining performed on two lymph node blocks to. exclude metastatic carcinoma; stains are negative. Prognostic markers: See previous biopsy report. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA. Specimen. A. Right axillary sentinel lymph node. B. Right breast mass, long anterior, short superior - tissue. Clinical Information. Right breast cancer;. year old black female with two side by side. cancers. Gross Description. A. Received unfixed, labeled right axillary sentinel node, are. 2. lymph nodes, 0.7 and 0.8 cm in greatest dimension each, entirely. submitted with each lymph node and a separate block (bisected). B. Received unfixed, and a transparent container, labeled right. breast mass, is a 5.5 x 4.3 x 3.0 cm portion of fibroadipose tissue. with orienting sutures. Margins are inked: Anterior black,. posterior blue, lateral green, and medial yellow. The specimen is. serially sectioned from superior to inferior. There is a 2.5 x 2.5. x 1.5 cm tumor mass, which is somewhat dumbbell-shaped, but appears. to consist of one tumor mass. Sections submitted as follows: 1. superior margin, 2 through 6 superior-most portion of tumor, 7. through 9 transition area of probable second lobe of tumor mass. (contiguous sections), 10 breast tissue intervening between tumor. mass and margin, 11 - inferior margin. Portion of tumor and normal. submitted for tissue procurement, as requested. Additional. sections submitted: RR1 intervening tissue between superior margin. and tumor; 2-4 additional superior tissue, 5-7 representative. remaining first half of specimen; 8-14 inferior half of specimen;. 15 additional inferior margin.

expanded version (tokens=1282) : 
 Histological classification:
- Invasive ductal carcinoma
- Ductal carcinoma in situ (DCIS)

Subtype:
- Histologic type of invasive carcinoma: Ductal
- Histologic pattern of DCIS: Solid, cribriform

Necrosis:
- Focal central necrosis in DCIS

Tumor infiltrating lymphocytes:
- No mention of tumor infiltrating lymphocytes

Histological grade:
- Invasive carcinoma histologic grade: 2
- DCIS nuclear grade: 2
- Overall grade: 7/9 (based on architectural score, nuclear score, and mitotic score)

Nuclear grade:
- Invasive carcinoma nuclear score: 2

Lymphovascular invasion:
- Not identified

Calcification:
- Not identified in invasive carcinoma or DCIS
- DCIS calcification: Negative

Receptor status:
- No information provided in this report on receptor status or any other ancillary testing results

Other findings:
- Invasive carcinoma present at the medial and posterior margins and possibly extending into surrounding fat
- DCIS present at the inferior margin of the specimen
- Confluence of tumor between two apparent masses suggests a single tumor mass lesion
- p63 immunostaining performed to confirm the presence of invasive carcinoma at the margin
- E-cadherin performed to exclude LCIS and confirm DCIS at the inferior margin
- Cytokeratin immunostaining performed on two lymph node blocks to exclude metastatic

